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Abstract 
Introduction:  The purpose of the present study was to assess the effects of acute nitrate (NO3
-
)-rich beetroot juice supplementation on peripheral oxygen saturation (SpO2), heart rate (HR), 
and pulmonary gas exchange during submaximal static and dynamic apnoea.  Methods:  Nine 
(six male, three female) trained apneists (age: 39.6  ±  8.2 years, stature: 170.4 ± 11.5cm, body 
mass: 72.0 ± 11.5 kg) performed three submaximal static apnoeas at 60%, 70% and 80% of the 
participant’s current reported personal best time, followed by three submaximal (~ 75% or 
personal best distance) dynamic apnoeas following the consumption of either a 140 ml 
concentrated NO3
--rich beetroot juice (BRJ; 7.7 mmol NO3
-) or a  NO3
--depleted placebo (PLA; 
0.1 mmol NO3
-) in double-blind randomised manner.  HR and SpO2 were measured via fingertip 
pulse oximetry at the nadir, and online gas analysis was used to assess pulmonary oxygen 
uptake (V̇O2) during recovery following breath-holds.  Results:  There were no differences (P 
<0.05) between conditions for HR  (PLA = 59 ± 11 bpm and BRJ = 61 ± 12 bpm), SpO2  (PLA 
= 83 ± 14% and BRJ = 84 ± 9%)  or V̇O2 (PLA = 1.00 ± 0.22 L.min-1 and BRJ = 0.97 ± 0.27 
L.min-1).  Conclusion:  The consumption of 7.7mmol of beetroot juice supplementation prior 
to a series of submaximal static and dynamic apnoeas did not induce a significant change in 
SpO2, HR and V̇O2, when compared to placebo. Therefore there is no apparent physiological 
response that may benefit free-divers as a result of the supplementation. 
 
Keywords:   Freediving, Breath-hold, Ergogenic aid.  
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Introduction 
Competitive apnoea also known as Free Diving or Breath-hold diving is an increasingly 
popular sport, in which individuals attempt to achieve the greatest possible stationary breath-
hold duration (i.e. static apnoea) or maximal underwater distance or depth (i.e. dynamic 
apnoea).  During apnoea, oxygen exchange with the environment is restricted, such that oxygen 
stored in the lungs and blood, and other tissue is drawn upon to meet the metabolic demands 
of the body (Schagatay et al., 2009).  As the apnoea continues, stored oxygen is gradually 
depleted, whilst carbon dioxide, lactate, and hydrogen (H+) ions accumulate (Schagatay, 2010).  
A low oxygen consumption is hence viewed as key to successful apnoea performance (for 
review see Schagatay, 2009; 2010; 2011), and strategies which minimise oxygen consumption 
are highly desired.   
  
Recently, dietary nitrate (NO3
-) supplementation has attracted considerable interest, following 
discovery of the NO3
--nitrite (NO2
-)-nitric oxide (NO) pathway – a means by which ingested 
or endogenously derived NO3
- can be converted into the pleiotropic signalling molecule NO 
(Lundberg et al., 2008).  NO3
- supplementation has been reported to enhance the efficiency of 
muscle contraction (Bailey et al., 2010) and mitochondrial respiration (Larsen et al., 2011), 
concomitantly reducing the oxygen cost of submaximal exercise (Larsen et al., 2007; Bailey et 
al., 2009; Pawlak-Chaouch et al., 2016).  Interestingly, generation of NO via the NO3
--NO2
--
NO pathway (Castello et al., 2006), and thus the physiological effects of NO3
- supplementation 
(Kelly et al., 2014), appear to be enhanced when oxygen availability is limited.  It is therefore 
possible that NO3
-  supplementation might be beneficial for apnoea performance.    
 It is logical to assume that NO3
- supplementation should only be used during maximal 
competitive efforts to allow for maximal stimulus during training; however it is suggested that 
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NO3
- may be a beneficial training aid allowing for increased training load due to reduced 
training fatigue (Mahoney et al, 2012).  
Engan et al. (2012) reported an increase in arterial oxygen saturation (SpO2), indicative of 
reduced tissue oxygen consumption, during a sub-maximal ‘dry’ (i.e. not submersed in water) 
apnoea after acute NO3
--rich (~5 mmol NO3
-) beetroot juice supplementation.  Maximal apnoea 
duration was also extended by 11 %.  Patrician and Schagatay (2016) also recently reported 
elevated post-exercise SpO2 values following sub-maximal horizontal underwater dives in a 
swimming pool subsequent to NO3
- -rich (~5 mmol) beetroot juice supplementation.  In 
contrast, potassium NO3
- supplementation decreased SpO2 and reduced maximal static apnoea 
duration (Schiffer et al. 2013).   In the same investigation, NO3
-  supplementation had no effect 
on SpO2 following maximal dynamic apnoea on a cycle ergometer (50 Watts at 60 rpm for 60 
and 90 sec) although maximal apnoea duration was no different between conditions  (Placebo 
119 ± 5.17 s vs. NO3
- 123 ± 6.4 s, P = 0.50) (Schiffer et al., 2013).  These conflicting findings 
may be related to differences in the NO3
- supplementation protocol, apnoea protocol, 
participant training status, and other methodological factors.  Consequently, further research is 
warranted to elucidate the potential efficacy of NO3
-  supplementation on apnoea performance.   
  
To date, no study has evaluated the effects of NO3
-  supplementation on the physiological 
response to underwater static apnoea, nor compared the effects of NO3
-  supplementation on 
underwater static and dynamic apnoea.  This provides a particularly interesting model for 
further exploration given the majority of apnoea competitions are conducted underwater, where 
the effects of NO3
-  supplementation might interact with the diving response, and potential 
differences in the effects of NO3
- supplementation during static and dynamic apnoea.  
Therefore, the purpose of the present study was to assess the effects of acute NO3
- -rich beetroot 
juice supplementation on SpO2, heart rate (HR), and pulmonary gas exchange during 
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submaximal static and dynamic apnoea.  In accordance with the recent investigation of 
Patrician & Schagatay (2016), we decided to explore the effects of NO3
-  supplementation on 
sub-maximal rather than maximal responses, which are predictive of maximal apnoea 
performance yet do not pose unnecessary health risks, including syncope, to participants.   
 
Methods 
Participants 
Nine (six male, three female) trained apneists (age: 39.62 ± 8.18 years, stature: 170.4 ± 11.5cm, 
body mass: 72.0 ± 11.5 kg) volunteered and provided fully informed written consent to take 
part in this study, approved by the institutional ethics committee at Leeds Beckett University, 
UK.  All participants were identified as ‘low risk’ according to the ACSM 2014 guidelines 
(Heyward & Gibson, 2014) prior to participation.  All of the participants were qualified as a 
minimum as 2* according to the qualifications of the International Association for the 
Development of Apnoea (AIDA) and were training specifically for free diving a minimum of 
three times per week and competing at a national level. Testing was conducted in accordance 
with the Declaration of Helsinki.  
 
Overview  
Participants visited the laboratory on three separate occasions over a three week period.  The 
first visit included pre-screening and familiarisation, which replicated the experimental testing 
procedures but without any intervention.  Subsequent visits comprised the experimental and 
placebo trials, and were conducted in a randomised order (randomisation was achieved using 
https://www.randomizer.org/), and preceded by the consumption of 140 ml concentrated NO3
- 
-rich beetroot juice (BRJ; 7.7 mmol NO3
-) or a NO3
- -depleted placebo (PLA; 0.1 mmol NO3
-) 
(Beet It, James White Drinks Ltd., Ipswich, UK).  Supplements were administered double-
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blind, two and a half hours before testing. The NO3
-  concentration of supplements was 
determined prior to testing via ozone based chemiluminescence, as previously described 
(Shannon et al. 2016). Participants were asked to abstain from intense exercise, alcohol, and 
caffeine on the day of testing, and consumption of food in the four hour period prior to each 
trial.  However, water was permitted ad libitum during this time to ensure adequate hydration.  
Testing was conducted in either a 21 m or 25 m swimming pool depending on participant 
residency and availability.  Participants wore either a nose-enclosed facemask or goggles and 
nose-clip, and a wetsuit, for the dive.  
 
Methodological considerations 
The present study included only submaximal apnoeas, given the unnecessary safety risks, 
including syncope, associated with maximal breath-holds.  The authors reasoned the 
submaximal apnoeas employed would be sufficient to invoke significant physiological 
changes, sufficient to detect difference between BRJ and PLA.  Only trained apneists were 
included (AIDA 2* and above), given the enhanced ability of this population to safely tolerate 
oxygen debt.  Additionally, the findings of this study are of greater relevance to this cohort, 
relative to non-divers.  An AIDA qualified safety diver was present at all trials, as a further 
safety precaution.  All apnoeas were performed at durations or distances relative to each diver’s 
recent personal best (within the month previous).  This was to ensure a relative physiological 
challenge across participants of sufficient intensity to make worthwhile observations whilst 
limiting the risk of syncope.    
 
Experimental trials 
Static apnoea protocol
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Each experimental trial commenced with three submaximal static apnoeas (STA) at 60%, 70% 1 
and 80% (140 ± 25 sec, 164 ± 29 sec, 187 ± 33 sec respectively) of the participant’s current 2 
reported personal best time (maximal duration) (mean personal best 234 ± 41 sec), separated 3 
with four minute recovery periods.  Participants entered the water two minutes prior to the first 4 
apnoea and a countdown was provided one and a half minutes before each breath-hold 5 
commenced.  A final inhalation was made, and a stopwatch was started at the moment the 6 
participant’s airway was closed.  Participants assumed a face-down floating position in the 7 
water, and were given regular time cues via taps throughout the apnoea.  Ten seconds before 8 
the end of the apnoea the participant withdrew their face from the water, and removed their 9 
facemask whilst still holding their breath until the end of the dive.   10 
 11 
Dynamic apnoea protocol 12 
Participants rested for 15 minutes following the static apnoea protocol.  They then performed 13 
three submaximal, dynamic apnoeas (DYN) separated by four minute recovery periods.   14 
Participants were required to swim underwater, covering a distance ~ 75 % of their current 15 
reported personal best (mean personal best 110 ± 22m actual distances performed ranged from 16 
50-100m).  Participants were permitted to swim with no fins (two participants), bi-fins (five 17 
participants) or a monofin (two participants) according to their preference.  Dynamic apnoeas 18 
were likewise preceded by a one and a half minute countdown before each breath-hold 19 
commenced.   20 
 21 
Measurements 22 
Heart rate and SpO2 were measured via fingertip pulse oximeter (Nellcor PM10N, Medtronic, 23 
MN, USA). The probe for registration of HR and SpO2 was attached to the forefinger for two 24 
minutes prior to each breath-hold.  Measurements were recorded immediately prior to the 25 
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commencement of each static and dynamic breath-hold.  As soon as the participant resurfaced 26 
from the breath-hold, the probe was placed back on the finger.  HR was recorded as soon as 27 
data was presented on the screen, i.e. within a few seconds. The post-apnoea SpO2 nadir, which 28 
was defined as the lowest SpO2 was achieved within in the one minute post-apnoea period, was 29 
also recorded. An online gas analysis system (Cortex Metamax 3B, Leipzig, Germany), 30 
calibrated according to the manufacturer's instructions, was used to assess the effects of NO3
- 31 
supplementation on pulmonary oxygen uptake (V̇O2) during breath-holds.  Expired air was 32 
collected in the final minute pre-apnoea, and the first minute post apnoea, through a face mask 33 
(Hans Rudolph, inc, MO, USA.) attached to the gas analysis system. V̇O2 was calculated as the 34 
volume of inspired oxygen (VIO2) minus the volume of expired oxygen (V̇EO2). 35 
 36 
Statistics 37 
Each subject served as their own control.  Separate two-way repeated measures ANOVAs were 38 
used to compare the HR, SpO2 and V̇O2 data between BRJ and PLA for static and dynamic 39 
apnoeas.  Statistical significance was accepted at P ≤ 0.05. Data are presented as mean (SD). 40 
All statistical analysis was performed using IBM SPSS Statistics 24. 41 
 42 
Results 43 
There was no difference in HR measured immediately pre-apnoea between PLA (mean ± SD) 44 
(80 ± 3) and BRJ (82 ± 17); P>0.05).   There were no differences between the PLA and BRJ 45 
conditions following any of the breath-holds.  When averaged across all STA trials, the overall 46 
mean post apnoea HR was 59 ± 11 bpm for PLA and 61 ± 12 bpm for BRJ; following the DYN 47 
overall mean post apnoea HR was 76 ± 15 bpm for the PLA  condition and 79 ± 16 bpm for 48 
the BRJ condition (Figure 1). 49 
 50 
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***Figure 1 Near Here*** 51 
 52 
There was no difference (P>0.05) in SpO2 between PLA and BRJ following any of the apnoeas.  53 
When averaged across all STA the mean SpO2 for the PLA condition was 82 ± 6% and 81 ± 54 
9% in the BRJ condition.  Following the DYN, the mean responses were 83 ± 14% and 84 ± 55 
9%for the PLA and BRJ conditions respectively.  Figure 2 shows the changes in SpO2 during 56 
static and dynamic apnoea. There were no differences in the absolute reduction of SpO2 under 57 
both conditions; the reduction during the STA in the PLA condition was 26 ± 10% and 27 ± 58 
11% in the BRJ condition.  Following the DYN, the mean change responses were 18 ± 12% 59 
and 28 ± 18% for the PLA and BRJ conditions respectively. 60 
 61 
****Figure 2 near here*** 62 
 63 
The results of V̇O2 following the STA and DYN apnoeas are presented in Figure 3.  Two-way 64 
repeated measures analysis found no differences following any of the apnoeas between PLA 65 
and BRJ.  Overall averages for post STA  V̇O2 were 1.00 ± 0.22 L.min-1 for PLA and 0.97 ± 66 
0.27L.min-1 for BRJ.   The overall average values were 1.70 ± 0.38 L.min-1 for PLA and 1.62 67 
± 0.40L.min-1 for BRJ following the DYN apnoeas. 68 
 69 
 70 
***Figure 3 Near here*** 71 
 72 
Discussion 73 
Dietary NO3
- supplementation has previously been reported to increase the 74 
bioavailability of NO and elicit an array of physiological responses that may be beneficial to 75 
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performance, including a lower oxygen cost at steady-state exercise (Larsen et al., 2007; Bailey 76 
et al., 2009; Pawlak-Chaouch et al., 2016), and elevated SpO2 in hypoxia (Masschelein et al., 77 
2012; Muggeridge et al., 2014; Bourdillon et al., 2015; Shannon et al., 2016; 2017).  The 78 
mechanisms underlying the oxygen sparing effect of NO3
- supplementation remain to be fully 79 
elucidated, but may be related to an improvement in either the efficiency of mitochondrial 80 
respiration (Larsen et al., 2011), and/or a reduced oxygen cost of muscle force generation 81 
(Bailey et al., 2010).  The reduction of NO2
- into NO is enhanced in hypoxic conditions, yet 82 
oxygen-dependent generation of NO via the L-arginine nitric oxide synthase (NOS) pathway 83 
is suppressed in hypoxia. Thus, NO3
- supplementation may be particularly effective at 84 
augmenting NO bioavailability, and hence influencing NO mediated physiological processes, 85 
in situations where oxygen availability is low (Lundberg et al., 2008).  Considering this 86 
background, the present study explored the effects of acute NO3
- supplementation on the 87 
physiological responses to submaximal static and dynamic apnoea.  The principle finding of 88 
this study is that NO3
- supplementation did not significantly alter any of the physiological 89 
responses to static or dynamic apnoeas.  An emerging view in literature is that highly-trained 90 
individuals may experience a diminished response to NO3
- supplementation (Jones, 2014).  For 91 
example, in runners, the improvement in performance consequent to NO3
- supplementation 92 
negatively correlated with V̇O2peak (Porcelli et al., 2014). The training status of apneists is not 93 
easily defined, but may be indicated by maximal apnoea duration and tolerance to arterial 94 
desaturation (Schiffer et al., 2013).  The participants in the current study were all competitive 95 
free-divers and as such may be considered well trained. 96 
 97 
It is possible that the dose of NO3
- administered in this study (7.7 mmol) was insufficient to 98 
significantly alter NO bioavailability, and therefore influence NO mediated physiological 99 
signalling.  Indeed, it is an acknowledged limitation of this study that we did not measure 100 
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plasma nor pulmonary markers of NO bioavailability.  However, similar (Wylie et al., 2013) 101 
and smaller (Muggeridge et al., 2014) doses of NO3
- have previously been demonstrated to 102 
increase plasma NO3
-, and elicit physiological and ergogenic effects.  Moreover, both Engan 103 
et al. (2012), and Patrician and Schagatay (2016) reported significant physiological changes 104 
following administration of a smaller NO3
-  dose (~ 5 mmol) and as such it would be expected 105 
that the dosage used here would have been sufficient. 106 
  107 
There are a number of methodological differences which may, in part, explain the disparate 108 
findings observed between the present study and previous research.  Apnoea duration may be 109 
influenced by physiological changes brought about through the mammalian diving reflex, 110 
demonstrated during breath-hold activity and characterised by bradycardia and peripheral 111 
vasoconstriction (Schagatay & Holm, 1996).  The current study did not find any differences in 112 
HR between the conditions, which is in agreement with previous studies; suggesting that BRJ 113 
had no effect on the bradycardia element of the diving reflex.  However, peripheral 114 
vasoconstriction is known to affect the values associated with pulse oximetry, with 115 
vasoconstriction reportedly increasing SpO2 (Talke et al; 2006).  It is well reported that NO3
- 116 
has a vasodilator response, although it is unclear how this may interact with the peripheral 117 
vasoconstriction element of the diving reflex.  Thus it is unclear how this may influence SpO2 118 
measurements during apnoeic conditions which are also influenced by immersion, water 119 
temperature, duration and the dynamic or static nature of the apnoea.    Therefore, these 120 
differences might be due to a lower and/or a delayed diving reflex effect, as a result of the 121 
vasodilatory effect of the NO3
-.  Suppression of the diving reflex may lead to an attenuation of 122 
the bradycardial effect and a lower peripheral vasoconstriction response, thus diminishing 123 
and/or delaying the oxygen conserving mechanism of the diving reflex.  This might lead to an 124 
earlier consumption of the readily available oxygen stores and a reduction in the maximal 125 
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apnoeic durations that can be achieved by an individual.   However, further research is required 126 
to elucidate whether NO3
- spares oxygen demand or increases it by blunting the diving reflex. 127 
 128 
Splenic contractions have also been reported to occur, following a series of repeated apnoeas 129 
(Schagatay, 2009).  The spleen serves as a red blood cell reservoir; splenic contractions develop 130 
progressively across apnoeas, and need several apnoeas to develop fully (3-5 repeated apnoeas) 131 
(Prommer et al., 2007; Schagatay, 2009).  During apnoeas Bakovic et al. (2003) identified a 132 
positive correlation between the extent of splenic contractions and the level of SpO2, therefore 133 
signifying that hypoxemia serves as a potent stimuli for evoking splenic contractions.   During 134 
contractions the spleen releases its stored red blood cells into circulation, increasing the oxygen 135 
reserve and readily available oxygen supply, enhancing carbon dioxide buffering; thus 136 
prolonging the apnoeic duration.  However, neither the current study nor previous studies 137 
(Engan et al, 2012; Patrician and Schagatay, 2016) reported values for splenic contractions 138 
following the administration of NO3
- supplementation.  Thus, it is currently unclear as to 139 
whether the vasodilatory effects of NO3
- supplementation result in changes in splenic 140 
contraction and whether this has any effect on breath-hold duration, HR or SpO2.  However, it 141 
is tempting to speculate that NO3
- supplementation may result in a delayed splenic effect. 142 
  143 
Conclusion 144 
The present study demonstrated that a consumption of 7.7mmol of beetroot juice 145 
supplementation prior to a series of submaximal (~75%) static and dynamic apnoeas, did not 146 
induce a change in SpO2, HR and V̇O2, when compared to placebo in nine (6 male; 3 female) 147 
competitive freedivers.  This suggests there is no apparent physiological response that may 148 
benefit free-divers as a result of the supplementation. 149 
 150 
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Figure Legends 311 
Figure 1. Heart Rate (beats.min-1) at cessation of apnoea for PLA and BRJ conditions. 312 
 313 
Figure 2.  Change in SpO2 from commencement to cessation of apnoea for PLA and BRJ 314 
conditions. 315 
 316 
Figure 3.  Recovery V̇O2 following cessation of apnoea for PLA and BRJ conditions. 317 
 318 
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